Taristine Tablet (Bepotastine Besilate)

Adult dose

In general, adults should take 10mg of bepotastine besilate orally twice daily. The dose may be adjusted according to age and symptoms.

This medicine should not be used in patients with hypersensitivity to its components. It should be administered with caution in patients with renal or hepatic impairment and in elderly patients. During treatment with this medication, neuropsychiatric symptoms such as drowsiness, headache, and dizziness, as well as gastrointestinal symptoms like dry mouth, vomiting, and diarrhea may occur. Furthermore, there may be changes in blood counts or liver function test results, so regular testing may be necessary. This medication can cause drowsiness, hence caution should be taken when driving or operating dangerous machinery. If a patient who has been on long-term steroid treatment takes this medication, the steroid dosage should be gradually reduced, and it must be managed under the supervision of a physician. In patients with decreased renal function, blood concentrations of this medication may increase, so it is advisable to start at a lower dose and carefully monitor their condition. Seasonal allergic rhinitis patients should use this medication cautiously, starting before the season when symptoms worsen and continuing during the symptom duration. If no effect is observed, it is advisable not to continue long-term use. This medication should avoid excessive alcohol consumption when taken with other antihistamines. Pregnant women or those who may become pregnant should preferably avoid this medication; if unavoidable, it should be administered cautiously based on a physician’s judgment. Breastfeeding women should also avoid this medication, as it may pass into breast milk. The safety of this medication in children has not been definitively established, thus caution is advised. Elderly patients should be administered this medication cautiously due to decreased renal function, which may prolong the drug's presence in the body. This medication may affect allergy test results, so it is advisable to discontinue use prior to testing. The tablet should be taken out of the packaging for administration, and care should be taken not to swallow the packaging. Keep out of reach of children, and store in a cool place away from moisture at temperatures below 30 degrees Celsius.

• drowsiness
• lethargy
• headache
• heaviness in the head
• dizziness
• dry mouth
• dry mucous membranes
• glossitis
• nausea
• vomiting

This medication must be stored in a tightly sealed container to prevent exposure to air or moisture. It is important to maintain room temperature between 1 and 30 degrees Celsius.

Appearance

White film-coated tablet with a score line

Package unit

30 tablets/bottle, 300 tablets/bottle